IN2015DN01018A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01018A IN2015DN01018A IN1018DEN2015A IN2015DN01018A IN 2015DN01018 A IN2015DN01018 A IN 2015DN01018A IN 1018DEN2015 A IN1018DEN2015 A IN 1018DEN2015A IN 2015DN01018 A IN2015DN01018 A IN 2015DN01018A
- Authority
- IN
- India
- Prior art keywords
- acetoxy
- propoxy
- diphenyl
- alkyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261681415P | 2012-08-09 | 2012-08-09 | |
| PCT/US2013/052626 WO2014025569A1 (en) | 2012-08-09 | 2013-07-30 | Piperidinium quaternary salts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01018A true IN2015DN01018A (es) | 2015-06-26 |
Family
ID=50068488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1018DEN2015 IN2015DN01018A (es) | 2012-08-09 | 2013-07-30 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9896416B2 (es) |
| EP (1) | EP2882711B1 (es) |
| JP (1) | JP6345665B2 (es) |
| KR (2) | KR102240999B1 (es) |
| CN (2) | CN104603108A (es) |
| AU (1) | AU2013300009B2 (es) |
| BR (1) | BR112015002832B1 (es) |
| CA (1) | CA2881182C (es) |
| EA (1) | EA029678B9 (es) |
| HK (1) | HK1211572A1 (es) |
| IL (1) | IL236996A0 (es) |
| IN (1) | IN2015DN01018A (es) |
| MX (1) | MX356386B (es) |
| WO (1) | WO2014025569A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3265128A4 (en) | 2015-03-06 | 2018-09-12 | Chase Pharmaceuticals Corporation | Oxybutynin transdermal therapeutic system muscarinic agonist combination |
| WO2017015349A1 (en) * | 2015-07-20 | 2017-01-26 | Chase Pharmaceuticals Corporation | Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for treating hypocholinergic disorders |
| JP7365613B2 (ja) | 2019-08-22 | 2023-10-20 | オフィノ， エルエルシー | マルチアクセスに対するポリシー制御 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD106643A1 (es) * | 1973-07-12 | 1974-06-20 | ||
| CN1285348A (zh) | 1999-08-20 | 2001-02-28 | 广东康美药业股份有限公司 | 盐酸丙哌维林合成工艺 |
| DE10129832A1 (de) * | 2001-06-17 | 2003-07-10 | Berolina Drug Dev Ab Svedala | Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel |
| CA2384922C (en) * | 2002-05-03 | 2008-09-02 | Purepharm Inc. | Topical glycopyrrolate product for the reduction of sweating |
| KR100500760B1 (ko) | 2003-07-22 | 2005-07-14 | 동방에프티엘 주식회사 | 염산 프로피베린의 제조방법 |
| KR100510788B1 (ko) | 2003-07-22 | 2005-08-26 | 동방에프티엘 주식회사 | 프로필벤질릭산 에스터로부터 염산 프로피베린의 제조방법 |
| SI1713473T1 (sl) * | 2004-02-06 | 2013-06-28 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in glukokortikoidov za dolgotranjno zdravljenje astme in KOPB |
| JP5541863B2 (ja) * | 2005-08-12 | 2014-07-09 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 神経雪崩アッセイ |
| CN1951938A (zh) * | 2005-10-21 | 2007-04-25 | 刘丽娅 | 戊乙奎醚季铵盐及其衍生物 |
| SE0600876L (sv) | 2006-04-20 | 2007-10-21 | Sandvik Intellectual Property | Verktyg och skär för spånavskiljande bearbetning med primära och sekundära ingreppsmedel med rotationssymmetrisk form |
| US20090233965A1 (en) * | 2006-04-24 | 2009-09-17 | Astrazeneca Ab | Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive Bladder |
| CN101490003A (zh) * | 2006-04-24 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | 具有毒蕈碱m3受体拮抗剂活性、用于治疗入慢性支气管阻塞、哮喘和膀胱过动的新型环状氨基醇的取代烷基酯类化合物 |
| WO2011114195A1 (en) * | 2010-03-15 | 2011-09-22 | Ramesha Andagar Ramakrishna | Synthesis of propiverine hydrochloride |
| KR101149821B1 (ko) | 2010-04-05 | 2012-05-24 | 하나제약 주식회사 | 디페닐아세테이트 유도체의 새로운 제조방법 |
| CN102218063B (zh) | 2011-04-12 | 2013-03-13 | 贵州神奇制药有限公司 | 盐酸丙哌维林药物的制备方法和产品及其检测方法 |
| MX2015002864A (es) * | 2012-09-05 | 2015-07-14 | Chase Pharmaceuticals Corp | Composicion neuroprotectora anticolinergica y metodos. |
-
2013
- 2013-07-30 JP JP2015526567A patent/JP6345665B2/ja active Active
- 2013-07-30 BR BR112015002832-2A patent/BR112015002832B1/pt not_active IP Right Cessation
- 2013-07-30 CN CN201380042085.3A patent/CN104603108A/zh active Pending
- 2013-07-30 MX MX2015001769A patent/MX356386B/es active IP Right Grant
- 2013-07-30 KR KR1020207005139A patent/KR102240999B1/ko active IP Right Grant
- 2013-07-30 CA CA2881182A patent/CA2881182C/en active Active
- 2013-07-30 AU AU2013300009A patent/AU2013300009B2/en not_active Ceased
- 2013-07-30 KR KR20157006047A patent/KR20150040355A/ko not_active Application Discontinuation
- 2013-07-30 EP EP13827594.6A patent/EP2882711B1/en active Active
- 2013-07-30 EA EA201500209A patent/EA029678B9/ru unknown
- 2013-07-30 WO PCT/US2013/052626 patent/WO2014025569A1/en active Application Filing
- 2013-07-30 IN IN1018DEN2015 patent/IN2015DN01018A/en unknown
- 2013-07-30 CN CN201810664740.3A patent/CN108658842A/zh active Pending
- 2013-07-30 US US14/419,381 patent/US9896416B2/en active Active
-
2015
- 2015-01-29 IL IL236996A patent/IL236996A0/en unknown
- 2015-12-10 HK HK15112219.3A patent/HK1211572A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9896416B2 (en) | 2018-02-20 |
| MX356386B (es) | 2018-05-28 |
| EA029678B1 (ru) | 2018-04-30 |
| CN104603108A (zh) | 2015-05-06 |
| BR112015002832A2 (es) | 2017-07-04 |
| EA201500209A1 (ru) | 2015-05-29 |
| KR20150040355A (ko) | 2015-04-14 |
| IL236996A0 (en) | 2015-03-31 |
| WO2014025569A1 (en) | 2014-02-13 |
| BR112015002832B1 (pt) | 2022-08-16 |
| CA2881182C (en) | 2021-01-26 |
| EP2882711A1 (en) | 2015-06-17 |
| US20150203452A1 (en) | 2015-07-23 |
| CN108658842A (zh) | 2018-10-16 |
| KR102240999B1 (ko) | 2021-04-15 |
| EP2882711B1 (en) | 2017-10-25 |
| EP2882711A4 (en) | 2016-02-10 |
| AU2013300009B2 (en) | 2017-06-15 |
| JP2015524469A (ja) | 2015-08-24 |
| MX2015001769A (es) | 2015-05-08 |
| EA029678B9 (ru) | 2018-07-31 |
| KR20200022522A (ko) | 2020-03-03 |
| CA2881182A1 (en) | 2014-02-13 |
| HK1211572A1 (en) | 2016-05-27 |
| JP6345665B2 (ja) | 2018-06-20 |
| AU2013300009A1 (en) | 2015-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013012542A (es) | Compuestos de amida y aplicacion farmaceutica para el mismo. | |
| EA201290984A1 (ru) | Гелеобразные фармацевтические композиции, препятствующие злоупотреблению | |
| PH12014502095A1 (en) | Estrogen receptor modulators and uses thereof | |
| MX2018003096A (es) | Composicion farmaceutica que contiene farmaco anionico, y metodo de preparacion para la misma. | |
| MX2015016171A (es) | Moduladores del receptor de estrogeno de azetidina y usos de los mismos. | |
| EA201201263A1 (ru) | Фармацевтическая композиция, содержащая этексилат дабигатрана | |
| IT1404931B1 (it) | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . | |
| IN2015DN03984A (es) | ||
| EA201201202A1 (ru) | Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана | |
| UY34730A (es) | Formulaciones farmacéuticas que comprenden antagonistas de ccr3 | |
| GEP201706739B (en) | Compositions comprising vortioxetine and donepezil | |
| BR112016014880A2 (pt) | Composição farmacêutica incluindo palonosetron | |
| MX2016001138A (es) | Compuestos de benzoxaborol triciclico, metodo de preparacion y uso del mismo. | |
| MY183914A (en) | Learning and memory improver | |
| PH12014502856B1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| IL246298B (en) | History of piperidine, their preparation and pharmaceutical preparations containing them | |
| MD20150053A2 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
| MX2017009827A (es) | Formulacion farmaceutica. | |
| PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| IN2015DN01018A (es) | ||
| IN2015DN02999A (es) | ||
| WO2015022560A8 (en) | Stable pharmaceutical composition containing bisoprolol and ramipril | |
| WO2015044434A3 (de) | FLUOR-9-METHYL-ß-CARBOLINE | |
| WO2017004172A8 (en) | Total synthesis of shishijimicin a and analogs thereof | |
| EP3091013A4 (en) | 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof |